Indoco Remedies' Goa Plant I has received EU GMP certification from the Malta Medicines Authority. The facility manufactures solid oral dosage forms and was inspected from November 19-24, 2025. This certification is crucial for accessing European markets.
Indoco Remedies' Goa Plant Receives EU GMP Certification
Indoco Remedies' Goa Plant I has achieved EU GMP certification from the Malta Medicines Authority. Reader Takeaway: Facility certification boosts export potential; operational compliance remains key. ## What just happened Indoco Remedies Ltd. has announced that its Goa Plant I, which produces solid oral dosage forms, has successfully obtained EU GMP certification following an inspection by the Malta Medicines Authority. The inspection took place from November 19 to November 24, 2025. ## Why this matters This certification is vital for Indoco Remedies as it validates the manufacturing practices at the Goa facility against European Union standards. It allows the company to continue exporting pharmaceutical products to European markets, thereby supporting its international business and revenue streams. ## The backstory Indoco Remedies operates a total of 10 manufacturing facilities, comprising 6 for Finished Dosage Forms (FDFs) and 4 for Active Pharmaceutical Ingredients (APIs). The company has a global presence and exports to numerous countries. Obtaining regulatory approvals like EU GMP is a continuous process critical for its operations. ## What changes now With the EU GMP certification in hand, Indoco Remedies' Goa Plant I can continue to supply products to the European Union without interruption. This reinforces the company's credibility and its ability to meet stringent quality requirements in regulated markets. ## Risks to watch While this is a positive development, ongoing adherence to Good Manufacturing Practices and successful navigation of future regulatory inspections across all its facilities remain critical for sustained market access. ## Peer comparison For pharmaceutical companies operating in India, achieving and maintaining EU GMP certification is a standard requirement for accessing lucrative European markets. Competitors like Dr. Reddy's Laboratories and Sun Pharmaceutical Industries also hold multiple EU GMP-approved facilities. ## Context metrics (time-bound) The inspection for this EU GMP certification was conducted between November 19 and November 24, 2025. ## What to track next Investors will likely monitor the company's export performance from this facility and any further regulatory updates or approvals for its other manufacturing units.
